Blepharitis Therapeutics Market, Global Outlook and Forecast 2022-2028

February 2022 | 62 pages | ID: B2F1989FF464EN
Market Monitor Global

Abstracts

Blepharitis is an inflammation of the eyelids in which they become red, irritated and itchy and dandruff-like scales form on the eyelashes. It is a common eye disorder caused by either bacteria or a skin condition, such as dandruff of the scalp or rosacea. It affects people of all ages. Although uncomfortable, blepharitis is usually not contagious and generally does not cause any permanent damage to eyesight.

This report contains market size and forecasts of Blepharitis Therapeutics in Global, including the following market information:

Global Blepharitis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Blepharitis Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Blepharitis Therapeutics include Bausch Health, Allergan, Novartis, LABORATORIES THEA, Akorn, NovaBay Pharmaceuticals and Scope Ophthalmics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blepharitis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Blepharitis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Blepharitis Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Antibiotics
• Steroids
• Other

Global Blepharitis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Blepharitis Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Retail Pharmacy
• Other

Global Blepharitis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Blepharitis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Blepharitis Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Blepharitis Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bausch Health
• Allergan
• Novartis
• LABORATORIES THEA
• Akorn
• NovaBay Pharmaceuticals
• Scope Ophthalmics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Blepharitis Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Blepharitis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BLEPHARITIS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Blepharitis Therapeutics Market Size: 2021 VS 2028
2.2 Global Blepharitis Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Blepharitis Therapeutics Players in Global Market
3.2 Top Global Blepharitis Therapeutics Companies Ranked by Revenue
3.3 Global Blepharitis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Blepharitis Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Blepharitis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Blepharitis Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Blepharitis Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Blepharitis Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Blepharitis Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Antibiotics
  4.1.3 Steroids
  4.1.4 Other
4.2 By Type - Global Blepharitis Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Blepharitis Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Blepharitis Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Blepharitis Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Blepharitis Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Retail Pharmacy
  5.1.4 Other
5.2 By Application - Global Blepharitis Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Blepharitis Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Blepharitis Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Blepharitis Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Blepharitis Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Blepharitis Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Blepharitis Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Blepharitis Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Blepharitis Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Blepharitis Therapeutics Revenue, 2017-2028
  6.3.2 US Blepharitis Therapeutics Market Size, 2017-2028
  6.3.3 Canada Blepharitis Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Blepharitis Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Blepharitis Therapeutics Revenue, 2017-2028
  6.4.2 Germany Blepharitis Therapeutics Market Size, 2017-2028
  6.4.3 France Blepharitis Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Blepharitis Therapeutics Market Size, 2017-2028
  6.4.5 Italy Blepharitis Therapeutics Market Size, 2017-2028
  6.4.6 Russia Blepharitis Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Blepharitis Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Blepharitis Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Blepharitis Therapeutics Revenue, 2017-2028
  6.5.2 China Blepharitis Therapeutics Market Size, 2017-2028
  6.5.3 Japan Blepharitis Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Blepharitis Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Blepharitis Therapeutics Market Size, 2017-2028
  6.5.6 India Blepharitis Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Blepharitis Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Blepharitis Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Blepharitis Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Blepharitis Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Blepharitis Therapeutics Market Size, 2017-2028
  6.7.3 Israel Blepharitis Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Blepharitis Therapeutics Market Size, 2017-2028
  6.7.5 UAE Blepharitis Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bausch Health
  7.1.1 Bausch Health Corporate Summary
  7.1.2 Bausch Health Business Overview
  7.1.3 Bausch Health Blepharitis Therapeutics Major Product Offerings
  7.1.4 Bausch Health Blepharitis Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Bausch Health Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Blepharitis Therapeutics Major Product Offerings
  7.2.4 Allergan Blepharitis Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Allergan Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Blepharitis Therapeutics Major Product Offerings
  7.3.4 Novartis Blepharitis Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 LABORATORIES THEA
  7.4.1 LABORATORIES THEA Corporate Summary
  7.4.2 LABORATORIES THEA Business Overview
  7.4.3 LABORATORIES THEA Blepharitis Therapeutics Major Product Offerings
  7.4.4 LABORATORIES THEA Blepharitis Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 LABORATORIES THEA Key News
7.5 Akorn
  7.5.1 Akorn Corporate Summary
  7.5.2 Akorn Business Overview
  7.5.3 Akorn Blepharitis Therapeutics Major Product Offerings
  7.5.4 Akorn Blepharitis Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Akorn Key News
7.6 NovaBay Pharmaceuticals
  7.6.1 NovaBay Pharmaceuticals Corporate Summary
  7.6.2 NovaBay Pharmaceuticals Business Overview
  7.6.3 NovaBay Pharmaceuticals Blepharitis Therapeutics Major Product Offerings
  7.6.4 NovaBay Pharmaceuticals Blepharitis Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 NovaBay Pharmaceuticals Key News
7.7 Scope Ophthalmics
  7.7.1 Scope Ophthalmics Corporate Summary
  7.7.2 Scope Ophthalmics Business Overview
  7.7.3 Scope Ophthalmics Blepharitis Therapeutics Major Product Offerings
  7.7.4 Scope Ophthalmics Blepharitis Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Scope Ophthalmics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Blepharitis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Blepharitis Therapeutics Market Drivers in Global Market
Table 3. Blepharitis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Blepharitis Therapeutics in Global Market
Table 5. Top Blepharitis Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Blepharitis Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Blepharitis Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Blepharitis Therapeutics Product Type
Table 9. List of Global Tier 1 Blepharitis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blepharitis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Blepharitis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Blepharitis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Blepharitis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Blepharitis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Blepharitis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Blepharitis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Blepharitis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Blepharitis Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Blepharitis Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Blepharitis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Blepharitis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Blepharitis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Blepharitis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Blepharitis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bausch Health Corporate Summary
Table 31. Bausch Health Blepharitis Therapeutics Product Offerings
Table 32. Bausch Health Blepharitis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Blepharitis Therapeutics Product Offerings
Table 35. Allergan Blepharitis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Blepharitis Therapeutics Product Offerings
Table 38. Novartis Blepharitis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. LABORATORIES THEA Corporate Summary
Table 40. LABORATORIES THEA Blepharitis Therapeutics Product Offerings
Table 41. LABORATORIES THEA Blepharitis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Akorn Corporate Summary
Table 43. Akorn Blepharitis Therapeutics Product Offerings
Table 44. Akorn Blepharitis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. NovaBay Pharmaceuticals Corporate Summary
Table 46. NovaBay Pharmaceuticals Blepharitis Therapeutics Product Offerings
Table 47. NovaBay Pharmaceuticals Blepharitis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Scope Ophthalmics Corporate Summary
Table 49. Scope Ophthalmics Blepharitis Therapeutics Product Offerings
Table 50. Scope Ophthalmics Blepharitis Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Blepharitis Therapeutics Segment by Type in 2021
Figure 2. Blepharitis Therapeutics Segment by Application in 2021
Figure 3. Global Blepharitis Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Blepharitis Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Blepharitis Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Blepharitis Therapeutics Revenue in 2021
Figure 8. By Type - Global Blepharitis Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Blepharitis Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Blepharitis Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Blepharitis Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Blepharitis Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Blepharitis Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Blepharitis Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Blepharitis Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Blepharitis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bausch Health Blepharitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Blepharitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Blepharitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. LABORATORIES THEA Blepharitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Akorn Blepharitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. NovaBay Pharmaceuticals Blepharitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Scope Ophthalmics Blepharitis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)